TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis

被引：0
|
作者：
M. Cole
C. Yap
C. Buckley
W. F. Ng
I. McInnes
A. Filer
S. Siebert
A. Pratt
J. D. Isaacs
D. D. Stocken
机构：
[1] Newcastle University,Population Health Sciences Institute
[2] The Institute of Cancer Research,Clinical Trials and Statistics Unit
[3] London,School of Immunity and Infection
[4] University of Birmingham,Translational and Clinical Research Institute
[5] Newcastle University,College of Medical, Veterinary and Life Sciences
[6] University of Glasgow,Leeds Institute of Clinical Trials Research
[7] University of Leeds,undefined
来源：
Trials | / 22卷
关键词：
CRM; Dose-finding; Adaptive; Early-phase; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Prospective Phase 1/2 Clinical Trial: Evaluating Dose-Escalation for Esophageal Cancer
    Welsh, J. W.
    Seyedin, S. N.
    Hofstetter, W. L.
    Ajani, J. A.
    Chang, J. Y.
    Gomez, D. R.
    Swisher, S. G.
    Blum, M. A.
    Nguyen, Q.
    Minsky, B. D.
    Erasmus, J.
    Lee, J. H.
    Bhutani, M. S.
    Komaki, R. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S12 - S13
  • [22] Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors
    Rahma, Osama E.
    Reuss, Joshua E.
    Giobbie-Hurder, Anita
    Razavi, Ghazaleh Shoja E.
    Abu-Shawer, Osama
    Mehra, Pooja
    Gupta, Seema
    Simon, Richard
    Khleif, Samir N.
    CLINICAL CANCER RESEARCH, 2021, 27 (02) : 485 - 491
  • [23] Adjusting perioperative methadone dose for elderly and fragile hip fracture patients (MetaHip-trial) - A statistical analysis plan for an adaptive dose-finding trial
    Pedersen, Andreas Kristian
    Heeboll, Kevin
    Petersen, Sofie Ronja
    Specht, Kirsten
    Strom, Thomas
    Moos, Caroline Margaret
    Skjot-Arkil, Helene
    Schonnemann, Jesper Ougaard
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 36
  • [24] A variation of a 2-in-1 adaptive design to seamlessly expand a selected dose from a phase 2 trial to a phase 3 trial for oncology drug development
    Zhang, Pingye
    Li, Xiaoyun
    Lu, Kaifeng
    Wu, Chengqing
    Ge, Miaomiao
    CONTEMPORARY CLINICAL TRIALS, 2023, 127
  • [25] Inhomogeneous dose escalation for NSCLC: Full dosimetric analysis of the phase III NARLAL2 trial
    Lutz, Christina M.
    Nielsen, Tine B.
    Lund, Mikkel D.
    Schytte, Tine
    Hansen, Torben S.
    Hoffmann, Lone
    Ottosson, Katarina W.
    Peucelle, Cecile
    Rusten, Espen
    Levin, Nina
    Brink, Carsten
    Gronberg, Bjorn H.
    Haakensen, Vilde D.
    Hansen, Olfred
    Khalil, Azza A.
    Knap, Marianne M.
    Kristiansen, Charlotte
    Nielsen, Morten
    Persson, Gitte F.
    Pohl, Mette
    Thing, Rune S.
    Moller, Ditte S.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1736 - S1739
  • [26] Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III Trial
    Moeller, Burkhard
    Everts-Graber, Judith
    Florentinus, Stefan
    Li, Yihan
    Kupper, Hartmut
    Finckh, Axel
    ARTHRITIS CARE & RESEARCH, 2018, 70 (06) : 861 - 868
  • [27] Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial
    Berry, Donald A.
    Dhadda, Shobha
    Kanekiyo, Michio
    Li, David
    Swanson, Chad J.
    Irizarry, Michael
    Kramer, Lynn D.
    Berry, Scott M.
    JAMA NETWORK OPEN, 2023, 6 (04) : e237230
  • [28] Dose Escalation to Target Volumes of Helical Tomotherapy for Pancreatic Cancer in the Phase 1-2 Clinical Trial
    Xia, T.
    Chang, D.
    Wang, Y.
    Li, J.
    Wu, W.
    Zhu, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S303 - S303
  • [29] Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
    Casazza, Joseph P.
    Hofstetter, Amelia R.
    Costner, Pamela J. M.
    Holman, LaSonji A.
    Hendel, Cynthia S.
    Widge, Alicia T.
    Wu, Richard L.
    Whalen, William R.
    Cunningham, Jennifer
    Arthur, Anita
    Wang, Xiaolin
    Ola, Abidemi
    Saunders, Jamie
    Mendoza, Floreliz
    Novik, Laura
    Burgos Florez, Maria C.
    Ortega-Villa, Ana M.
    Apte, Preeti J.
    Strom, Larisa
    Wang, Lu
    Imam, Marjaan
    Basappa, Manjula
    Naisan, Mursal
    Castro, Mike
    Trost, Jessica F.
    Narpala, Sandeep R.
    Vanderven, Hillary A.
    Yamshchikov, Galina V.
    Berkowitz, Nina M.
    Gordon, Ingelise J.
    Plummer, Sarah H.
    Wycuff, Diane L.
    Vazquez, Sandra
    Gillespie, Rebecca A.
    Creanga, Adrian
    Adams, William C.
    Carlton, Kevin
    Gall, Jason G.
    Mcdermott, Adrian B.
    Serebryannyy, Leonid A.
    Houser, Katherine V.
    Koup, Richard A.
    Graham, Barney S.
    Ledgerwood, Julie E.
    Mascola, John R.
    Pierson, Theodore C.
    Andrews, Sarah F.
    Kanekiyo, Masaru
    Dropulic, Lesia K.
    NPJ VACCINES, 2024, 9 (01)
  • [30] Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis
    Marcora, Samuele M.
    Chester, Kathryn R.
    Mittal, Gayatri
    Lemmey, Andrew B.
    Maddison, Peter J.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 84 (06): : 1463 - 1472
12345